Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis

Abstract

ObjectiveActivated T cells are the main component of the inflammatory skin infiltrates that characterise systemic sclerosis (SSc). Our aim was to investigate the efficacy of abatacept, which tempers T-cell activation,...